Stock Valuation Methods — How to Price a Business

Stock valuation methods are the techniques used to estimate what a share is actually worth, independent of its current price. They fall into two families: absolute methods that value a business by its own cash flows, and relative methods that price it against comparable companies. The output is an estimate of intrinsic value, which you then weigh against the market price to decide whether a stock is expensive, cheap, or fairly valued.

That last sentence is where most people go wrong. A valuation is not a price target the market owes you. It is a probability-weighted view that holds only while the assumptions behind it hold. Treat it as a range with a margin of error, not a single number, and the methods below become far more useful.

What stock valuation methods actually measure

Stock valuation is the process of determining the intrinsic value of a share using a company's fundamentals rather than its quoted price. The meaning is straightforward: you are trying to answer one question. What is this business worth, and is the market currently paying more or less than that?

Every method is a different route to the same destination. Absolute valuation builds the number from the inside out, using the company's own cash flows, earnings, or dividends. Relative valuation builds it from the outside in, using what investors are willing to pay for similar businesses right now. Neither is more correct. They answer slightly different questions, and a serious analysis usually runs both.

The reason this matters is positioning. Price reflects what the crowd believes today. Intrinsic value is your estimate of what the business can deliver over time. The gap between the two, when it exists, is the entire opportunity. Valuation is the tool that measures that gap with discipline instead of opinion.

Absolute methods value the business by its own cash

Absolute, or intrinsic, methods ignore the rest of the market and price a company on what it generates internally. Three carry most of the weight.

• Discounted cash flow (DCF). You project the free cash flow a business will produce over a forecast period, then discount each year back to today using a rate that reflects risk. The sum is the present value of the company. DCF is the most theoretically complete method because it values a business on the only thing that ultimately matters, the cash it returns to owners.

• Dividend discount model (DDM). A focused version of DCF for companies that pay steady dividends. You discount expected future dividends instead of total free cash flow. It suits mature, dividend-paying names and breaks down quickly for companies that reinvest everything and pay nothing.

• Asset-based valuation. You value the company by its net assets, taking what it owns and subtracting what it owes. This is most relevant for asset-heavy businesses, holding companies, or liquidation scenarios, and least relevant for asset-light businesses whose value lives in brand, software, or network effects.

The strength of absolute methods is independence. They do not care what comparable stocks trade at, so they can flag when an entire sector is mispriced. The weakness is sensitivity. The output depends heavily on your growth and discount-rate assumptions, and small changes in those inputs move the answer substantially. A half-point shift in the discount rate, or a single point off the long-term growth assumption, can swing the intrinsic estimate by double digits. That is why analysts who lean on these models run several scenarios rather than a single base case, and why a clean-looking number deserves more skepticism than it usually gets.

Relative methods price a stock against its peers

Relative valuation, the world of valuation ratios, compares a stock to similar companies using multiples. Instead of building value from cash flows, you ask what the market pays per unit of earnings, sales, or book value, then apply that benchmark to the company in front of you.

The common multiples are familiar:

• Price-to-earnings (P/E) divides share price by earnings per share. It tells you what investors pay for each dollar of profit.

• Price-to-book (P/B) divides market value by book value of equity, useful for financials and asset-heavy firms.

• EV/EBITDA compares enterprise value to operating earnings before non-cash and financing items, which makes it cleaner for comparing companies with different debt loads.

This is where the cluster question of stock valuation methods versus valuation ratios resolves. Ratios are not a separate discipline. They are the engine of the relative method. A multiple on its own says nothing. A P/E of 30 is only expensive or cheap once you set it against a benchmark, the company's own history, its direct peers, or the broader market.

Relative valuation is fast and grounded in real prices, which is its appeal. Its weakness is circularity. If the entire peer group is overpriced, a relative model will call an overpriced stock fairly valued, because it is measuring against an inflated baseline.

How to calculate a valuation, with a worked formula

The DCF formula is the one worth internalizing, because the logic underneath it sits beneath almost every other method. In plain terms, the value of a stock is the sum of its future cash flows, each divided by one plus the discount rate raised to the power of the year it arrives.

Work an example with round numbers. Suppose a company is expected to generate 10 dollars per share in free cash flow next year, 11 the year after, and 12 the year after that, and you use a 10 percent discount rate. You divide 10 by 1.10, 11 by 1.21, and 12 by 1.331, which gives roughly 9.09, 9.09, and 9.02. Add a terminal value to capture cash beyond year three, discount that back as well, and the total is your intrinsic estimate per share.

The relative calculation is simpler. Take the peer-group average P/E, multiply it by the company's earnings per share, and you have an implied price. If comparable firms trade at 18 times earnings and this company earns 4 dollars per share, the relative model points to roughly 72 dollars.

Notice what both calculations share. The arithmetic is trivial. The judgment is not. Your growth rate, your discount rate, and your choice of comparable companies decide the answer long before the math does.

How to interpret the number and use it in stock analysis

A valuation only earns its place when it changes a decision. The interpretation step is where investors actually use these methods, and it comes down to comparing your intrinsic estimate against the market price.

If intrinsic value sits well above the price, the stock may be undervalued, and the gap is your potential margin. If it sits well below, the market is paying for expectations the fundamentals may not support. If the two are close, valuation is telling you the stock is fairly priced and the edge, if any, lies elsewhere.

The discipline that separates analysis from guessing is the margin of safety. Because every input is an estimate, you do not act on a hairline gap. You require intrinsic value to exceed price by a meaningful cushion before the difference means anything, so that ordinary forecasting error does not turn a fair price into a false signal. A valuation is a range, not a point. Interpreting it as a single exact figure is the most common beginner mistake, and it produces false precision that the market punishes.

Used well, valuation answers the practical question directly: it tells you whether a stock is expensive relative to what the business can realistically deliver, and it gives you a reason to act or to wait that is grounded in the company rather than the price chart.

When valuation methods break down

No single method works across all conditions, and pretending otherwise is how careful-looking analysis still loses money. Each method has an environment where it stops describing reality.

DCF degrades the moment cash flows become hard to forecast. For an early-stage company with no stable earnings, the model becomes an exercise in defending whatever assumption you started with. The output looks rigorous and is mostly an opinion in a spreadsheet. Relative valuation inverts during bubbles and panics, when the entire peer group is mispriced and the benchmark itself is wrong, so a comparable model quietly endorses the mistake. Asset-based methods understate businesses whose real value is intangible.

There is a deeper limitation worth stating plainly. Valuation tells you what a business is worth. It does not tell you when the market will agree with you. A stock can stay mispriced far longer than a forecast horizon, and acting on intrinsic value without respecting that timing risk is how patient analysis turns into a slow drawdown. The number is an input to a decision, not the decision itself. The strongest analysts hold their valuation loosely, update it as the facts change, and treat a wide gap between their estimate and the market as a question to investigate rather than a verdict to trade.

FAQs

What is stock valuation in simple terms? It is the process of estimating what a share is actually worth based on the underlying business, then comparing that estimate to the market price. If your estimate is meaningfully higher than the price, the stock may be undervalued; if it is lower, the market may be paying for more than the fundamentals support.

Which stock valuation method is the most reliable? No single method is reliable across all conditions. Discounted cash flow is the most complete in theory because it values a business on the cash it generates, but it is only as good as its assumptions. Most disciplined analysis runs both an absolute method and a relative one, then treats agreement between them as a stronger signal than either alone.

What is the difference between stock valuation methods and valuation ratios? Valuation ratios such as P/E and P/B are not a separate discipline. They are the engine of the relative valuation method, which prices a stock against comparable companies. A ratio in isolation means nothing until you compare it to a benchmark like the company's own history, its peers, or the broader market.